The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice
Hack-Lyoung Kim, Jae-Bin Seo, Woo-Young Chung, Sang-Hyun Kim, Myung-A Kim, Joo-Hee Zo
Korean J Intern Med. 2014;29(5):588-596.   Published online 2014 Aug 28     DOI: https://doi.org/10.3904/kjim.2014.29.5.588
Citations to this article as recorded by Crossref logo
Insulin-like growth factor-1 activates PI3K/Akt signalling to protect human retinal pigment epithelial cells from amiodarone-induced oxidative injury
Rifang Liao, Fengxia Yan, Zhuanping Zeng, Haitao Wang, Kaifeng Qiu, Jinying Xu, Wenhua Zheng
British Journal of Pharmacology.2018; 175(1): 125.     CrossRef
Medical Management of Rheumatic Heart Disease
E. Anne Russell, Warren F. Walsh, Ben Costello, Alex J. A. McLellan, Alex Brown, Christopher M. Reid, Lavinia Tran, Graeme P. Maguire
Cardiology in Review.2018; 26(4): 187.     CrossRef
Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy
Stephen Rankin, Douglas H. Elder, Simon Ogston, Jacob George, Chim C. Lang, Anna Maria Choy
Cardiovascular Therapeutics.2017; 35(3): e12258.     CrossRef
The clinical value of regular thyroid function tests during amiodarone treatment
Stan Benjamens, Robin P F Dullaart, Wim J Sluiter, Michiel Rienstra, Isabelle C van Gelder, Thera P Links
European Journal of Endocrinology.2017; 177(1): 9.     CrossRef
A Late Presentation of Amiodarone -Induced Hepatotoxicity
Adriaan Dees
MOJ Clinical & Medical Case Reports.2016;[Epub]     CrossRef
Adverse effects of long-term amiodarone therapy
Hyoung-Seob Park, Yoon-Nyun Kim
The Korean Journal of Internal Medicine.2014; 29(5): 571.     CrossRef